COMMUNIQUÉS West-GlobeNewswire

Commure Named “Overall NLP Company of the Year” in 2026 AI Breakthrough Awards
25/06/2026
Recognition highlights Commure’s AI-native platform transforming healthcare operations at scale MOUNTAIN VIEW, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Commure , a leading healthcare technology company, today announced [...]
Survey Exposes a Crisis of Avoidance in Family Caregiving
25/06/2026
Older Adults Want to Age at Home: Just 1 in 5 Have Told Loved Ones What They Actually Want LOUISVILLE, Ky., June 25, 2026 (GLOBE NEWSWIRE) -- A comprehensive new national survey commissioned by LogicMark, Inc. (OTC: [...]
Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering
25/06/2026
NEW YORK and TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “ Company ” or “ Helus Pharma ”), a clinical stage pharmaceutical company committed to helping minds heal by [...]
Eliaz Therapeutics Highlights Selective Galectin-3 Removal in Sepsis, Advances XGAL-3® Program
25/06/2026
Santa Rosa, United States, June 25, 2026 (GLOBE NEWSWIRE) -- Eliaz Therapeutics Announces Publication Highlighting Selective Galectin-3 Removal Approach in Sepsis and Advancement of XGAL-3 Development Program Company [...]
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
25/06/2026
HOUSTON, June 25, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV ) (“Plus” or the “Company”), announced today that it has signed a national agreement [...]
Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
25/06/2026
Topline Phase 3 Results from C-FORWARD Expected Around Year-End 2026 More Than 880 HCV Treatment-Naïve Patients Enrolled Across 17 Countries Outside North America C-FORWARD and C-BEYOND Represent the First Global Phase [...]
Canadian Red Cross and Walmart Canada launch annual giving campaign
25/06/2026
Funds raised support disaster relief in communities across Canada OTTAWA, June 25, 2026 (GLOBE NEWSWIRE) -- As Canadians face an active start to the wildfire season and communities continue to recover from recent floods [...]
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
25/06/2026
Nasdaq-Listed Biotech Pioneer Among the First Companies to Operate at adMare's New M4 Innovation Centre RENO, Nev., June 25, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (“ Conexeu” or the “Company”), a [...]
AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet
25/06/2026
Favourable safety profile in marked contrast to traditional inotropic therapeutics AC01 showed rapid and sustained numerical improvements in cardiac output, structure and function STOCKHOLM, Sweden, June 25, 2026 – [...]
BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™
25/06/2026
Agreement supports potential commercial readiness for Bria-IMT using Uneedle’s proprietary microneedle technology for intradermal administration Technology is currently used in BriaCell’s pivotal Phase 3 study and is [...]
Medera Announces Independent Data Monitoring Committee (DMC) Recommends Continued Advancement of Lead HFpEF Gene Therapy Program
25/06/2026
Independent DMC recommends continued conduct of the MUSIC-HFpEF study without protocol modification following scheduled review of accumulated clinical data; randomized HFrEF Phase 2 study also reviewed with no safety [...]
Ernexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific Strategy and Vision for Patients
25/06/2026
New platform provides additional perspective on Ernexa's mission to deliver hope for patients through innovative, scalable cell therapies while improving accessibility and affordability Inaugural video highlights [...]
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
25/06/2026
ALAMEDA, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, [...]
La Croix-Rouge canadienne et Walmart Canada donnent le coup d’envoi à la campagne de financement annuelle
25/06/2026
Les fonds recueillis permettront d’aider les communautés partout au Canada lors de situations d’urgence OTTAWA, 25 juin 2026 (GLOBE NEWSWIRE) -- Alors que le Canada connaît un début de saison des feux de forêt occupé et [...]
Lycia Therapeutics Raises $75 Million in Oversubscribed Financing and Strengthens Leadership Team with Appointment of Chief Financial Officer and General Counsel
25/06/2026
Financing co-led by Janus Henderson Investors and Balyasny Asset Management, with participation from Adage Capital Management, HBM Healthcare Investments, OrbiMed and continued support from existing investors Proceeds [...]
Daré Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5™ in Virtual Investor “What This Means” Segment
25/06/2026
First consumer health product positions Daré for revenue generation while expanding its women's health leadership platform Access the segment here SAN DIEGO, June 25, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. ( [...]
Glass House Brands Announces Uplist to NYSE
25/06/2026
LONG BEACH, Calif. and TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the “Company”) (CBOE CA: GLAS.A.U) (OTCQX: GLASF) today announced that its subordinate voting shares (the “ [...]
Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer
25/06/2026
Brings more than 25 years of global drug development, regulatory and strategic leadership experience successfully guiding innovative therapies from clinical development through regulatory approval and commercialization [...]
New PerfectServe Research: 85% of Healthcare Leaders Want to Switch Their Contact Center Vendors, But Most Feel Trapped
25/06/2026
Survey of 105 IT and operational leaders reveals tech fragmentation that harms patient experience and complicates operators’ working environment MIAMI, June 25, 2026 (GLOBE NEWSWIRE) -- PerfectServe ® , a leading [...]

Pages